Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Christopher J. Kochansky"'
Autor:
Chunhui Huang, Christian Fischer, Michelle R. Machacek, Stephane Bogen, Tesfaye Biftu, Xianhai Huang, Michael H. Reutershan, Ryan Otte, Qingmei Hong, Zhicai Wu, Yang Yu, Min Park, Lei Chen, Purakkattle Biju, Ian Knemeyer, Ping Lu, Christopher J. Kochansky, Michael Brendan Hicks, Yong Liu, Roy Helmy, Xavier Fradera, Anthony Donofrio, Josh Close, Matthew L. Maddess, Catherine White, David L. Sloman, Nunzio Sciammetta, Jun Lu, Craig Gibeau, Vladimir Simov, Hongjun Zhang, Peter Fuller, David Witter
Publikováno v:
ACS Med Chem Lett
[Image: see text] Mutant isocitrate dehydrogenase 1 (IDH1) has been identified as an attractive oncology target for which >70% of grade II and III gliomas and ∼10% of acute myeloid leukemia (AML) harbor somatic IDH1 mutations. These mutations confe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13ecfd534a4182e5c705a82b16c3ffcc
https://europepmc.org/articles/PMC9014435/
https://europepmc.org/articles/PMC9014435/
Autor:
Mark Wrona, Ismael Zamora, Mark T. Cancilla, Tatiana Radchenko, Gordon Murray, Christopher J. Kochansky, Jayne Kirk, Fabien Fontaine, Russell J. Mortishire-Smith
Publikováno v:
Rapid Communications in Mass Spectrometry. 34
Rationale Liquid chromatography/mass spectrometry is an essential tool for efficient and reliable quantitative and qualitative analysis and underpins much of contemporary drug metabolism and pharmacokinetics. Data-independent acquisition methods such
Autor:
Gordon Murray, Fabien Fontaine, Ismael Zamora, Tatiana Radchenko, Mark T. Cancilla, Jayne Kirk, Russell J. Mortishire-Smith, Mark Wrona, Christopher J. Kochansky
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::700d648398d7c9503f4357619072f911
https://doi.org/10.1002/rcm.8792/v2/response1
https://doi.org/10.1002/rcm.8792/v2/response1
Publikováno v:
Lipids. 53:947-960
Proteins involved in lipid homeostasis are often regulated through the nuclear peroxisome proliferator-activated receptors (PPAR). PPARα is the target for the fibrate-class of drugs. Fenofibrate has been approved for its lipid-lowering effects in pa
Autor:
Anil P. D'mello, Veron Browne, Claudia Mendez-Garcia, Afsana Trini, Laura Pontiggia, Christopher J. Kochansky
Publikováno v:
Canadian journal of physiology and pharmacology. 97(10)
Protein restriction throughout pregnancy and lactation reduces liver triglyceride (TG) content in adult male rat offspring. The study determined the contribution of hepatic lipogenesis to the reduction in liver TG content. Rats received either contro
Autor:
Andreas Brink, Christopher J. Kochansky, Tatiana Radchenko, Luca Morettoni, Alison Bateman, Fabien Fontaine, Yves Siegrist, Ismael Zamora
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 11, p e0186461 (2017)
PLoS ONE, Vol 12, Iss 11, p e0186461 (2017)
Interest in using peptide molecules as therapeutic agents due to high selectivity and efficacy is increasing within the pharmaceutical industry. However, most peptide-derived drugs cannot be administered orally because of low bioavailability and inst
Autor:
Donald F. Hora, Suzanne L. Ciccotto, James R. Reed, Stella H. Vincent, Christopher J. Kochansky, David Q. Liu, Shiyao Xu, Ralph A. Stearns, Maria G. Beconi, Charles S. Elmore, Yohannes Teffera, Yuan-Qing Xia
Publikováno v:
Drug Metabolism and Disposition. 35:525-532
The pharmacokinetics, metabolism, and excretion of sitagliptin [MK-0431; (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine], a potent dipeptidyl peptidase 4 inhibitor, were eva
Autor:
Vanessa L. Sherman, M. Reza Anari, Catherine M. Wiscount, Julie A. Krueger, Christopher J. Kochansky, Bobby J. Lucas, Tran Lekhanh O, Joseph P. Vacca, Terry A. Lyle, Bradley K. Wong, Sanderson Philip E, Heidi L. Shimp, Peter D. Williams, Sean Yu, Donnette D. Staas, Kelly L. Savage, S. Dale Lewis, Rebecca B. White, Youwei Yan, Daniel R. McMasters
Publikováno v:
Bioorganic & Medicinal Chemistry. 14:6900-6916
Previous reports from our laboratories described potent tripeptide thrombin inhibitors which incorporate heterocycle-substituted chlorophenyl groups in the P1 position. Using these as lead compounds for further optimization, we identified sites of me
Publikováno v:
Drug Metabolism and Disposition. 34:2073-2078
Drug transporters have been shown to alter drug metabolism. Similarly, bioactivation of drugs may also be altered by drug transporters. The aim of this work was to examine the role of P-glycoprotein (Pgp) in the bioactivation of a Pgp substrate, ralo
Autor:
Christopher J. Kochansky, Donald F. Hora, Sui Wang, Stella H. Vincent, K Lynn, Zhen Wang, J Brunner, Mi-Sook Kim, Zhongzhou Shen, Ronald B. Franklin
Publikováno v:
Xenobiotica. 34:665-674
1. The metabolism and pharmacokinetics of two structurally similar PPAR agonists, MRL-I, (2R)-7-[3-[2-chloro-4-(4-fluorophenoxy)phenoxy]propoxy]-2-ethyl-3,4-dihydro-2H-benzopyran-2-carboxylic acid, and MRL-II, (2R)-7-[3-[2-chloro-4-(2,2,2,-trifluoroe